Blood test study for soft tissue sarcoma patients
Part of Cancer clinical trials.
This study is testing a new blood test that looks for circulating tumor cells in your blood. The goal is to see if this test can help doctors make better treatment decisions for soft tissue sarcoma, potentially improving how the disease is managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with soft tissue sarcoma (a type of cancer that starts in soft tissues), not including a rare type called GIST.
- Your cancer has spread to other parts of the body or is in a location that cannot be fully removed by surgery, and your doctor has decided to start treatment with a chemotherapy drug called an anthracycline.
- You have at least one tumor that can be measured on a scan.
- You are well enough to be up and about for at least half of your waking hours (performance status 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune system “fingerprints” using tumor tissue from people with rare soft tissue sarcoma. It may help researchers understand what drives these cancers and guide future treatments.
This study checks if a blood test can detect DNA from soft tissue sarcomas. The goal is to see if circulating tumor DNA can help doctors monitor the disease and plan treatment.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
This trial tests whether a medicine injected directly into a tumor can shrink or control advanced soft tissue sarcoma. It mainly looks for people whose tumors can be safely injected with a hand exam or ultrasound.
This trial tests whether taking a special medication (5-ALA) before surgery makes the sarcoma glow under a special light, helping the surgeon see and remove the cancer more completely. The goal is to reduce the chance of leaving any cancer behind.
This trial tests a newer way of giving radiation (spatially fractionated) compared to standard radiation for people with large soft tissue sarcomas. It aims to see if the new method works better.
Hear when a new Diagnosis of Soft Tissue Sarcoma (STS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.